Omalizumab |
Xolair |
Image:Omalizumab.png Omalizumab Systematic (IUPAC) name ? Identifiers CAS number 242138-07-4 ATC code R03DX05 PubChem ? DrugBank BTD00081 Chemical data Formula C6450H9916N1714O2023S38 Mol. weight 145058.2 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life 26 days Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Xolair® allergic asthma medicaiton. Omaliz ...
Wikipedia - [full article]
Omalizumab News Headlines
- FDA Proposes To Strengthen Label Warning For Xolair
MedicalNewsToday - Mon, 26 Feb 2007 09:00 EST
- Xolair ''add-on'' helpful in uncontrolled dermatitis
Reuters - Fri, 13 Jan 2006 04:18 EST
- Severe Allergic Asthma - Xolair® (omalizumab) add-on therapy significantly reduces attacks
MedicalNewsToday - Sun, 10 Jul 2005 06:00 EST
- Life-threatening asthma attacks - Xolair® halves rate of severe exacerbations for patients
MedicalNewsToday - Sat, 28 May 2005 06:00 EST

Not Signed In -


